| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| NHIVNewHold Investment Corp IV | $278.04M | — | — | — | — | $1.33M | — | AI pending |
| RWAYRunway Growth Finance Corp. | $278.28M | 61.5× | $137.33M | -5.0% | $34.05M | $10.83M | $678.95M | AI pending |
| TGTredegar Corp | $278.5M | 8.5× | $800.82M | +8.3% | $24.86M | $17.18M | $46M | AI pending |
| FRAFFranklin Financial Services Corp | $279.02M | 11.3× | $88.82M | +24.8% | $21.23M | $195.03M | $0 | AI pending |
| FATEFate Therapeutics Inc | $279.18M | — | $6.65M | -51.2% | -$136.32M | $32.43M | $13.93M | AI pending |
| DBHLDeep Isolation Nuclear, Inc. | $279.69M | — | $6.14M | -13.0% | -$5.34M | $19.38M | — | AI pending |
| YSGYatsen Holding Ltd | $279.71M | — | CN¥4.3B | +26.7% | -CN¥80.87M | CN¥765.38M | — | AI pending |
| PAIIPyrophyte Acquisition Corp. II | $279.76M | 46.3× | — | — | — | $1.14K | — | AI pending |
| ISNRSnow Rothschild Acquisition Corp. | $279.96M | — | — | — | — | $1.24M | — | AI pending |
| ELDNEledon Pharmaceuticals, Inc. | $280.35M | — | $0 | — | -$5.66M | $6.8M | — | AI pending |
| FXNCFirst National Corp | $280.68M | 12.9× | $14.29M | +0.8% | $17.7M | $166.15M | $6.05M | AI pending |
| XCBEX3 Acquisition Corp. Ltd. | $280.97M | 96.5× | — | — | — | $644.21K | — | AI pending |
| BDSXBiodesix Inc | $280.98M | — | $88.5M | +24.1% | -$35.27M | $30M | $50M | AI pending |
| AXINAxiom Intelligence Acquisition Corp 1 | $281.12M | 35.3× | — | — | — | $289.54K | — | AI pending |
| CAMPCamp4 Therapeutics Corp | $281.13M | — | $3.5M | +436.5% | -$80.4M | $86.4M | — | AI pending |
| BGSB&G Foods, Inc. | $281.21M | — | $1.83B | -5.4% | -$43.26M | $591.58M | $2.52B | AI pending |
| ATLOAmes National Corp | $281.31M | 12.3× | $66.83M | +21.9% | $19.03M | $107.24M | $18.35M | AI pending |
| TTRXTurn Therapeutics Inc. | $281.79M | — | — | — | — | $9.95M | $6.06M | AI pending |
| SRZNSurrozen, Inc. | $281.97M | — | $3.48M | -67.4% | -$242.03M | $102.04M | — | AI pending |
| ALXOAlx Oncology Holdings Inc | $282.09M | — | $0 | — | -$123.48M | $22.69M | $9.71M | AI pending |